Close

Of yeast and men: reducing toxic effects of TDP-43 as a potential treatment for MND

Reading Time: 4 minutes A collaborative American research group, led by Prof Aaron Gitler from Stanford University School of Medicine in California, has identified a potential therapeutic target for MND using yeast. The toxic activity of the MND-linked protein TDP-43 was suppressed when a gene called DBR1 was deleted from yeast and mammal cells. The study marks the first…

Deserved recognition

Reading Time: 2 minutes At the end of the opening session of the International Symposium on ALS/MND, two members of the MND research community were recognised for their contribution to the field. Professor Orla Hardiman, from Trinity College, Dublin is this year’s recipient of the Forbes Norris Award. Presented by Dee Forbes Norris, this award recognises care and compassion…